SE316172B - - Google Patents

Info

Publication number
SE316172B
SE316172B SE7232/64A SE723264A SE316172B SE 316172 B SE316172 B SE 316172B SE 7232/64 A SE7232/64 A SE 7232/64A SE 723264 A SE723264 A SE 723264A SE 316172 B SE316172 B SE 316172B
Authority
SE
Sweden
Application number
SE7232/64A
Inventor
R Joly
J Warnant
J Jolly
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE316172B publication Critical patent/SE316172B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7232/64A 1963-07-10 1964-06-12 SE316172B (xx)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR941004A FR1375078A (fr) 1963-07-10 1963-07-10 Procédé d'introduction d'une fonction oxygénée en position 11 de certains 19-norstéroïdes et produits en résultant
FR951379A FR1468639A (fr) 1963-07-10 1963-10-22 Nouveau stéroïde diénique 11-oxygéné et procédé de préparation
FR960726A FR5089M (xx) 1963-07-10 1964-01-17
FR971005A FR3845M (fr) 1963-07-10 1964-04-15 Nouveau médicament notamment pour le traitement de l'hypercholestérolémie et des troubles en résultant.

Publications (1)

Publication Number Publication Date
SE316172B true SE316172B (xx) 1969-10-20

Family

ID=27445615

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7231/64A SE316170B (xx) 1963-07-10 1964-06-12
SE7232/64A SE316172B (xx) 1963-07-10 1964-06-12

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7231/64A SE316170B (xx) 1963-07-10 1964-06-12

Country Status (10)

Country Link
US (2) US3301756A (xx)
BE (2) BE649223A (xx)
BR (2) BR6459890D0 (xx)
CH (2) CH433276A (xx)
DE (2) DE1229526B (xx)
DK (2) DK112796B (xx)
FR (4) FR1375078A (xx)
GB (3) GB1074491A (xx)
NL (3) NL6406711A (xx)
SE (2) SE316170B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123455C (xx) * 1964-05-13
US3389153A (en) * 1965-08-13 1968-06-18 Merck & Co Inc 3-enol ethers of 17alpha-haloethynyl-estra 3, 5(10), 9(11)-trien-17beta-ols
FR205F (xx) * 1965-10-22
NL129874C (xx) * 1966-03-15
US3475469A (en) * 1967-06-27 1969-10-28 American Home Prod 13 - alkyl - 9 - chloromethylgon - 4-en-17beta-ol-3-ones and intermediates therefor
CN101208369B (zh) * 2005-06-28 2013-03-27 E.I.内穆尔杜邦公司 高功函数透明导体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3211764A (en) * 1963-09-25 1965-10-12 American Cyanamid Co 19-norandrostadienes and method of preparing the same

Also Published As

Publication number Publication date
BR6459890D0 (pt) 1973-08-09
US3301756A (en) 1967-01-31
FR1375078A (fr) 1964-10-16
GB1074495A (en) 1967-07-05
DK119107B (da) 1970-11-16
GB1074491A (en) 1967-07-05
FR1468639A (fr) 1967-02-10
FR5089M (xx) 1967-05-22
SE316170B (xx) 1969-10-20
US3282785A (en) 1966-11-01
DE1232577B (de) 1967-01-19
DE1229526B (de) 1966-12-01
CH432504A (fr) 1967-03-31
BE649223A (xx)
DK112796B (da) 1969-01-20
NL6406711A (xx) 1965-01-11
BR6459891D0 (pt) 1973-09-11
NL6406712A (xx) 1965-01-11
NL121957C (xx)
BE649224A (xx)
GB1074492A (en) 1967-07-05
CH433276A (fr) 1967-04-15
FR3845M (fr) 1966-01-17

Similar Documents

Publication Publication Date Title
FR5089M (xx)
BE627012A (xx)
BE627141A (xx)
BE624070A (xx)
BE645242A (xx)
BE644791A (xx)
BE643871A (xx)
BE621517A (xx)
BE622160A (xx)
BE642812A (xx)
BE642663A (xx)
BE642632A (xx)
BE630890A (xx)
BE628145A (xx)
BE644911A (xx)
BE627151A (xx)
BE627145A (xx)
BE627172A (xx)
BE645449A (xx)
BE626826A (xx)
BE627023A (xx)
BE644325A (xx)
BE626986A (xx)
BE626938A (xx)
BE626915A (xx)